Skip to main content

Table 3 Association between MetS components and the presence or absence of MetS

From: Metabolic syndrome in haemodialysis patients: prevalence, determinants and association to cardiovascular outcomes

  

MsWC

MsHBP

MsHDL

MsTG

MsGlc

Total population

Sensitivity

80.23

93.6

69.81

68.89

84.6

Specificity

82.28

26.8

89.66

84.48

57.14

PPV

90.79

73.52

93.28

90.16

81.98

NPV

65.66

65.62

59.09

56.81

61.69

Men

Sensitivity

69.86

93.97

71.37

70.61

84.56

Specificity

89.61

23.28

91.33

84.00

54.68

PPV

92.49

69.19

93.50

88.52

78.50

NPV

61.88

67.92

64.62

62.07

64.41

Women

Sensitivity

92.74

93.16

67.91

66.82

84.65

Specificity

68.67

32.53

86.59

85.37

61.54

PPV

89.30

79.56

92.99

92.36

86.55

NPV

77.03

62.79

50.71

49.30

57.83

  1. MetS Metabolic syndrome. PPV Positive predictive value. NPV Negative predictive value. MsWC Waist circumference > 102 cm in men or > 88 cm in women. MsHBP High blood pressure or antihypertensive drugs. MsHDL HDL cholesterol < 0.50 g/L in women or <  0.40 g/L in men. MsTG TG ≥1.5 g/L. MsGlc Fasting glucose ≥1.00 g/L.